¼¼°èÀÇ ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¿¹Ãø(2024-2032³â)
Molecular Transport Medium Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
Persistence Market Research´Â ºÐÀÚ ¿î¼Û ¹èÁö ¼¼°è ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ º¸°í¼¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ º¸°í¼´Â ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, µ¿Çâ, ±âȸ ¹× °úÁ¦¸¦ Æ÷ÇÔÇÑ Áß¿äÇÑ ½ÃÀå ¿ªÇÐÀ» öÀúÈ÷ Æò°¡ÇÏ°í ½ÃÀå ±¸Á¶¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù.
ÁÖ¿ä ÀλçÀÌÆ®
ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå ±Ô¸ð(2024E) : 11¾ï 4,700¸¸ ´Þ·¯
½ÃÀå ¿¹ÃøÄ¡(2032F) :12¾ï 7,200¸¸ ´Þ·¯
¼¼°è ½ÃÀå ¼ºÀå·ü(CAGR 2024³âºÎÅÍ 2032³â±îÁö) : 1.3%
ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå-º¸°í ¹üÀ§:
ºÐÀÚ ¿î¼Û ¹èÁö´Â ƯÈ÷ °¨¿°ÀÇ Áø´Ü °Ë»ç¸¦ À§ÇÑ ÀÓ»ó Ç¥º»ÀÇ º¸Á¸°ú ¼ö¼Û¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ ¹èÁö´Â Á¤È®ÇÑ ºÐÀÚ ºÐ¼®À» À§ÇØ RNA¿Í DNA »ùÇÃÀÇ ¹«°á¼ºÀ» À¯ÁöÇϵµ·Ï Ưº°È÷ ¼³°èµÇ¾úÀ¸¸ç ´Ù¾çÇÑ Áúº´À» Áø´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀåÀº º´¿ø, Áø´Ü ½ÇÇè½Ç, Á¶»ç ±â°ü, »ý¸í °øÇÐ ±â¾÷¿¡ ¼ºñ½º¸¦ Á¦°øÇÏ¸ç ¹ÙÀÌ·¯½º, ¹ÚÅ׸®¾Æ ¹× ¹ü¿ë ¿î¼Û ¹èÁö¸¦ Æ÷ÇÔÇÑ ´Ù¾çÇÑ ¼ö¼Û ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº Áø´Ü °Ë»ç ¼ö¿ä Áõ°¡, °¨¿°Áõ À¯Çà Áõ°¡, ºÐÀÚÁø´Ü ±â¼úÀÇ Áøº¸¿¡ ÀÇÇÑ ½Ã·á º¸Á¸ ¹× ¼ö¼Û È¿À²ÀÇ Çâ»óÀÔ´Ï´Ù.
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ:
¼¼°èÀÇ ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀåÀº Á¤È®ÇÑ Áø´Ü °Ë»ç, ƯÈ÷ COVID-19, ÀÎÇ÷翣ÀÚ ¹× ±âŸ ½ÅÈï º´¿øÃ¼¿Í °°Àº ¹ÙÀÌ·¯½º °¨¿°¿¡ ´ëÇÑ ¿ä±¸ Áõ°¡¿Í °°Àº ¸î °¡Áö Áß¿äÇÑ ¿äÀο¡ ÀÇÇØ ÃßÁøµÇ°í ÀÖ½À´Ï´Ù. Àü¿°º´ÀÇ ¼¼°è À¯Çà°ú ±×¿¡ µû¸¥ ºÐÀÚÁø´ÜÀ» À§ÇÑ ½Å·ÚÇÒ ¼ö ÀÖ´Â ¿î¼Û ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå È®´ë°¡ ´õ¿í °ÈµÇ°í ÀÖ½À´Ï´Ù. ¹ÙÀÌ·¯½º ºÒȰ¼ºÈ ¿î¼Û ¹èÁö °³¹ß ¹× ½Ã·á º¸Á¸ ±â¼ú °È¿Í °°Àº ±â¼úÀû Áøº¸´Â Áø´Ü °Ë»çÀÇ Á¤È®¼ºÀ» Çâ»ó½ÃŰ°í ¿À¿° À§ÇèÀ» ÁÙÀÌ°í ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡, À¯ÀüüÇÐ¿Í ¸ÂÃãÇü ÀÇ·á¿¡¼ÀÇ ¿¬±¸°³¹ß Ȱµ¿¿¡ ´ëÇÑ ÁÖ¸ñ Áõ°¡´Â ÷´Ü ºÐÀڰ˻翡 Æ¯ÈµÈ ¿î¼Û ¹èÁö¸¦ Á¦°øÇÏ´Â ½ÃÀåÂü°¡ÀÚ¿¡°Ô »õ·Î¿î ±âȸ¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù.
½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ:
À¯¸ÁÇÑ ¼ºÀå Àü¸Á¿¡µµ ºÒ±¸Çϰí, ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀåÀº ±ÔÁ¤ Áؼö, °ø±Þ¸Á È¥¶õ, ºñ¿ë Á¦¾à°ú °ü·ÃµÈ ¹®Á¦¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. ¿î¼Û ¸ÅüÀÇ Á¦Á¶, ¿î¼Û ¹× »ç¿ëÀ» ±ÔÁ¤ÇÏ´Â ¾ö°ÝÇÑ ±ÔÁ¦´Â Á¦Á¶¾÷ü¿¡ ÄÄÇöóÀ̾𽺿¡ ºÎ´ãÀ» ÁÖ¾î ½ÃÀå ÁøÀÔ À庮 ¹× ¿î¿µ ºñ¿ë¿¡ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. °Ô´Ù°¡, ƯÈ÷ ¼¼°è º¸°Ç º¸°Ç ±ä±Þ »óȲ¿¡¼´Â °ø±Þ¸Á ¹®Á¦°¡ Áß¿äÇÑ ¿î¼Û ¸Åü ºÎÁ·À¸·Î À̾îÁ® Áø´Ü °Ë»ç ´É·Â¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. Ư¼ö ºÐÀÚ ¿î¼Û ¹èÁöÀÇ ºñ¿ëÀÌ ³ô°í ÀÌ¿ë °¡´ÉÇÑ Áö¿ªÀÌ Á¦ÇѵǾî ÀÖ´Â °ÍÀº ƯÈ÷ ÀÇ·á ¿¹»ê¿¡ Á¦¾àÀÌ ÀÖ´Â ½ÅÈï °æÁ¦±¹¿¡¼ ½ÃÀå ħÅõÀÇ °úÁ¦°¡ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±ÔÁ¦ ¹× ¹°·ù À庮À» ÇØ°áÇϱâ À§Çؼ´Â ¾ÈÀüÇϰí È¿°úÀûÀÎ ¿î¼Û ¼Ö·ç¼ÇÀÇ Áö¼ÓÀûÀÎ °ø±ÞÀ» º¸ÀåÇϱâ À§ÇØ ¾÷°è ÀÌÇØ °ü°èÀÚ¿Í Á¤Ã¥ ÀÔ¾ÈÀÚÀÇ Çù·ÂÀÌ ÇÊ¿äÇÕ´Ï´Ù.
½ÃÀå ±âȸ:
ºÐÀÚ ¿î¼Û ¹èÁö½ÃÀåÀº ±â¼ú Çõ½Å, Á¶»çȰµ¿ È®´ë, ÇコÄɾî Á¦°ø ¸ðµ¨ÀÇ ÁøÈ¸¦ ¿øµ¿·ÂÀ¸·Î ÇÏ´Â Å« ¼ºÀå ±âȸ¸¦ Á¦½ÃÇϰí ÀÖ½À´Ï´Ù. ÀÚµ¿ÈµÈ ½Ã·á Ãë±Þ°ú ¿î¼Û ±â¼úÀÇ ÅëÇÕÀº ½ÇÇè½ÇÀÇ È¿À²¼ºÀ» ³ôÀ̰í Áø´Ü ¿öÅ©Ç÷ο쿡¼ ÀÎÀ§ÀûÀÎ ½Ç¼ö¸¦ ÁÙ¿©ÁÝ´Ï´Ù. °Ô´Ù°¡, ¸ÂÃãÇü ÀÇ·á ¹× À¯ÀüüÇÐ ¿¬±¸¿¡ ÀÖ¾î¼ÀÇ ºÐÀÚ ¿î¼Û ¹èÁöÀÇ ÀÀ¿ë È®´ë°¡ ½ÃÀåÀÇ ¹üÀ§¸¦ ³ÐÇô ±â¼ú Çõ½ÅÀ» ÀÚ±ØÇϰí ÀÖ½À´Ï´Ù. Àü·«Àû ÆÄÆ®³Ê½Ê, R&D ÅõÀÚ, ºñ¿ë È¿À²ÀûÀÎ ¿î¼Û ¼Ö·ç¼ÇÀÇ µµÀÔÀº »õ·Î¿î ±âȸ¸¦ Ȱ¿ëÇÏ°í ¿ªµ¿ÀûÀÎ ºÐÀÚ ¿î¼Û ·£µå½ºÄÉÀÌÇÁ¿¡¼ ½ÃÀåÀÇ ¸®´õ½ÊÀ» À¯ÁöÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù.
ÀÌ º¸°í¼¿¡¼ ´Ù·ç´Â ÁÖ¿ä Áú¹®
ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀåÀÇ ¼¼°è ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡?
¾î¶² ¿î¼Û ¸ÅüÀÇ À¯Çü°ú ¿ëµµ°¡ ´Ù¾çÇÑ ÇコÄɾî ȯ°æ¿¡¼ÀÇ Ã¤¿ëÀ» ÃËÁøÇϰí Àִ°¡?
±â¼ú Áøº¸´Â ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå °æÀï ±¸µµ¸¦ ¾î¶»°Ô ¹Ù²Ù°í Àִ°¡?
ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå¿¡ ±â¿©ÇÏ´Â ÁÖ¿ä ±â¾÷Àº ´©±¸ÀÌ¸ç ½ÃÀå °ü·Ã¼ºÀ» À¯ÁöÇϱâ À§ÇØ ¾î¶² Àü·«À» äÅÃÇϰí Àִ°¡?
¼¼°èÀÇ ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå¿¡¼ÀÇ »õ·Î¿î µ¿Çâ°ú Àü¸ÁÀº?
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå ½ÃÀå °³¿ä
½ÃÀå ¹üÀ§/ºÐ·ù
½ÃÀåÀÇ Á¤ÀÇ/¹üÀ§/Á¦ÇÑ
Æ÷ÇÔ°ú Á¦¿Ü
Á¦3Àå ÁÖ¿ä ½ÃÀå µ¿Çâ
½ÃÀå¿¡ ¿µÇâÀ» ÁÖ´Â ÁÖ¿ä µ¿Çâ
Á¦Ç° Çõ½Å/°³¹ß µ¿Çâ
Á¦4Àå ÁÖ¿ä ³»¿ë
Á¦Ç° ä¿ë ºÐ¼®
Á¦Á¶¾÷ü°¡ ä¿ëÇÑ ÁÖ¿ä Àü·«
±ÔÁ¦ ½Ã³ª¸®¿À
PESTLE ºÐ¼®
Porter's Five Forces ºÐ¼®
¹ë·ùüÀÎ ºÐ¼®
Á¦5Àå ½ÃÀå ¹è°æ
°Å½Ã°æÁ¦ ¿äÀÎ
¿¹Ãø ¿äÀÎ- °ü·Ã¼º°ú ¿µÇâ
½ÃÀå ¿ªÇÐ
Á¦6Àå COVID-19 À§±â ºÐ¼®
2024³â ½ÃÀå ½Ã³ª¸®¿À
COVID-19¿Í ¿µÇ⠺м®
Á¦Ç° À¯Çü
¿ëµµº°
»ùÇú°
ÃÖÁ¾ »ç¿ëÀÚº°
Áö¿ªº°
Á¦7Àå ¼¼°è ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå - °¡°Ý ºÐ¼®
¼¼°è Æò±Õ °¡°Ý ºÐ¼® º¥Ä¡¸¶Å©
°¡°ÝÀÇ »óÁ¤
Á¦8Àå ¼¼°èÀÇ ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå ¼ö¿ä(°¡Ä¡ ¶Ç´Â ±Ô¸ð, 10¾ï ´Þ·¯) ºÐ¼®
½ÃÀå ¸ÅÃâ(10¾ï ´Þ·¯) ºÐ¼®, 2019-2023³â
½ÃÀå ¸ÅÃâ(10¾ï ´Þ·¯) ¿¹Ãø, 2024-2032³â
Àü³â´ëºñ ¼ºÀå µ¿Ç⠺м®
Àý´ë ¼öÀÍ ±âȸ
Á¦9Àå Á¦Ç° À¯Çüº°: ¼¼°èÀÇ ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå ºÐ¼®
¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®, 2019-2023³â
½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, 2024-2032³â
Ȱ¼ºÈ ¿î¼Û ¹èÁö
ºÒȰ¼ºÈ ¿î¼Û ¹èÁö
Á¦10Àå ¿ëµµº° : ¼¼°èÀÇ ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå ºÐ¼®
¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®, 2019-2023³â
½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, 2024-2032³â
¹ÙÀÌ·¯½º
COVID-19
Áßµ¿ È£Èí±â ÁõÈıº(MERS)
ÀÎÇ÷翣ÀÚ
COVID-19
Àΰ£ ¸é¿ª°áÇÌ ¹ÙÀÌ·¯½º(HIV)
¸®³ë¹ÙÀÌ·¯½º
¾Æµ¥³ë¹ÙÀÌ·¯½º
È£Èí±â ÇÕÆ÷ü ¹ÙÀÌ·¯½º(RSV)
¹ÚÅ׸®¾Æ
Æ÷µµ»ó±¸±Õ¼º Æó·Å
ÀÎÇ÷翣ÀÚ±Õ
źÀú±Õ
±âŸ
ºñÁ¤Çü ¼¼±Õ
°áÇÙ±Õ ¹× Áø±Õ °¨¿°
Á¦11Àå »ùÇú°: ¼¼°èÀÇ ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå ºÐ¼®
¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®, 2019-2023³â
½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, 2024-2032³â
ÄÚ ¼¼Ã´°ú ¸éºÀ
°´´ã
Ÿ¾×
´ë¹ø
¼Òº¯
ÇÇ
Ƽ½´
±âŸ
Á¦12Àå ÃÖÁ¾ »ç¿ëÀÚº°: ¼¼°èÀÇ ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå ºÐ¼®
¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®, 2019-2023³â
½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, 2024-2032³â
Áø´Ü ½ÇÇè½Ç
¹Ì»ý¹°ÇÐ ¿¬±¸¼Ò
º´¿ø ¹× Ŭ¸®´Ð
±âŸ
Á¦13Àå Áö¿ªº°: ¼¼°èÀÇ ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå ºÐ¼®
¼Ò°³
½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®, 2019-2023³â
½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, 2024-2032³â
ºÏ¹Ì
¶óƾ¾Æ¸Þ¸®Ä«
À¯·´
³²¾Æ½Ã¾Æ
µ¿¾Æ½Ã¾Æ
¿À¼¼¾Æ´Ï¾Æ
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«)
Á¦14Àå ºÏ¹Ì ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå ºÐ¼®
Á¦15Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå ºÐ¼®
Á¦16Àå À¯·´ÀÇ ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå ºÐ¼®
Á¦17Àå ³²¾Æ½Ã¾Æ ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå ºÐ¼®
Á¦18Àå µ¿¾Æ½Ã¾ÆÀÇ ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå ºÐ¼®
Á¦19Àå ¿À¼¼¾Æ´Ï¾ÆÀÇ ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå ºÐ¼®
Á¦20Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ºÐÀÚ ¿î¼Û ¹èÁö ½ÃÀå ºÐ¼®
Á¦21Àå ½ÃÀå ±¸Á¶ ºÐ¼®
±â¾÷ Tierº° ½ÃÀå ºÐ¼®
ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
½ÃÀå ÁýÁß
½ÃÀåÇöÀçºÐ¼®
Á¦22Àå °æÀï ºÐ¼®
°æÀï ´ë½Ãº¸µå
°æÀï º¥Ä¡¸¶Å·
°æÀïÀÇ »ó¼¼
Thermo Fisher Scientific
Becton Dickinson and Company
Cardinal Health
Quidel Corporation
Medical Wire &Equipment(MWE)
COPAN Diagnostics Inc.(COPAN Group)
Titan Biotech Ltd.
Alpha Teknova, Inc.(formerly named Teknova)
Bio-Genex Laboratories Inc.
EKF Diagnostics
Trinity Biotech
Alpha-Tec Systems, Inc.
Charm Sciences, Inc.
Azer Scientific
bioBoaVista
AccuGene
KSL Diagnostics
Puritan Medical Products
Amazing Biotech(Shanghai) Co., Ltd.
Á¦23Àå »ç¿ëµÈ ÀüÁ¦Á¶°Ç°ú ¾à¾î
Á¦24Àå Á¶»ç ¹æ¹ý
JHS
Persistence Market Research has recently released a comprehensive report on the worldwide market for molecular transport medium. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.
Key Insights:
Molecular Transport Medium Market Size (2024E): USD 1.147 Billion
Projected Market Value (2032F): USD 1.272 Billion
Global Market Growth Rate (CAGR 2024 to 2032): 1.3%
Molecular Transport Medium Market - Report Scope:
Molecular transport medium plays a crucial role in preserving and transporting clinical specimens for diagnostic testing, particularly for infectious diseases. This medium is specifically designed to maintain the integrity of RNA and DNA samples for accurate molecular analysis, aiding in the diagnosis of various conditions. The molecular transport medium market serves hospitals, diagnostic laboratories, research institutions, and biotechnology companies, offering a range of transport solutions, including viral, bacterial, and general-purpose transport mediums. Market growth is driven by the increasing demand for diagnostic testing, rising prevalence of infectious diseases, and advancements in molecular diagnostics technology, enhancing specimen preservation and transportation efficiency.
Market Growth Drivers:
The global molecular transport medium market is propelled by several key factors, including the growing need for accurate diagnostic testing, particularly for viral infections like COVID-19, influenza, and other emerging pathogens. The rising prevalence of infectious diseases globally and the subsequent demand for reliable transport solutions for molecular diagnostics further drive market expansion. Technological advancements, such as the development of viral inactivation transport mediums and enhanced specimen preservation technologies, offer improved accuracy in diagnostic testing and reduce the risk of contamination, fostering market growth. Moreover, the increasing focus on research and development activities in genomics and personalized medicine creates new opportunities for market players to provide specialized transport mediums for advanced molecular testing.
Market Restraints:
Despite promising growth prospects, the molecular transport medium market faces challenges related to regulatory compliance, supply chain disruptions, and cost constraints. Stringent regulations governing the manufacturing, transportation, and use of transport mediums impose compliance burdens on manufacturers, affecting market entry barriers and operational costs. Furthermore, supply chain issues, particularly during global health emergencies, can lead to shortages of critical transport mediums, impacting diagnostic testing capacities. The high cost of specialized molecular transport mediums and limited availability in certain regions pose challenges for market penetration, particularly in emerging economies with constrained healthcare budgets. Addressing these regulatory and logistical barriers requires collaboration between industry stakeholders and policymakers to ensure the continuous supply of safe and effective transport solutions.
Market Opportunities:
The molecular transport medium market presents significant growth opportunities driven by technological innovations, expanding research activities, and evolving healthcare delivery models. The integration of automated specimen handling and transport technologies enhances laboratory efficiency and reduces human error in diagnostic workflows. Furthermore, the growing application of molecular transport mediums in personalized medicine and genomics research broadens the market scope and stimulates innovation. Strategic partnerships, investment in research and development, and the introduction of cost-effective transport solutions are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic molecular transport landscape.
Key Questions Answered in the Report:
What are the primary factors driving the growth of the molecular transport medium market globally?
Which transport medium types and applications are driving adoption across different healthcare settings?
How are technological advancements reshaping the competitive landscape of the molecular transport medium market?
Who are the key players contributing to the molecular transport medium market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global molecular transport medium market?
Competitive Intelligence and Business Strategy:
Leading players in the global molecular transport medium market, including Thermo Fisher Scientific, Becton, Dickinson and Company, and COPAN Diagnostics Inc., focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced transport mediums, including viral inactivation solutions and enhanced stabilization formulas, catering to diverse diagnostic needs and research requirements. Collaborations with healthcare providers, diagnostic laboratories, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and customer education fosters market growth and enhances specimen integrity in the rapidly evolving molecular diagnostics landscape.
Key Companies Profiled:
Thermo Fisher Scientific
Becton, Dickinson and Company
COPAN Diagnostics Inc.
Puritan Medical Products
BioMed Diagnostics
Hardy Diagnostics
Longhorn Vaccines & Diagnostics
Titan Biotech Ltd.
Starplex Scientific
HiMedia Laboratories
Key Segments Covered in Molecular Transport Medium Industry Research
Molecular Transport Medium Market by Product Type:
Active Transport Medium
Inactivated Transport Medium
Molecular Transport Medium Market by Application:
Virus
Bacteria
Atypical Bacteria
Mycobacterial and Fungal Infection
Molecular Transport Medium Market by Sample:
Nasal Washes and Swabs
Sputum
Saliva
Faecal & Stool
Urine
Blood
Tissues
Molecular Transport Medium Market by End User:
Diagnostic Laboratories
Microbiology Laboratories
Hospitals & Clinics
Molecular Transport Medium Market by Region:
North America
Latin America
Europe
South Asia
East Asia
Oceania
The Middle East & Africa
Table of Contents
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Inclusions
4.1. Product Adoption Analysis
4.2. Key Strategies Adopted by Manufacturers
4.3. Regulatory Scenario
4.4. PESTLE Analysis
4.5. Porter's Analysis
4.6. Value Chain Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Outlook
5.1.2. Global Healthcare Spending Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. COVID-19 Pandemic
5.2.2. Product Launches
5.2.3. GDP Growth
5.2.4. Increasing Prevalence of Infectious Diseases
5.2.5. R&D Expenditure by Key Players
5.2.6. Product Adoption Rate
5.2.7. Regulatory Scenario
5.2.8. Strategic Acquisitions and Mergers among Key Players
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. 2024 Market Scenario
6.2. COVID-19 and Impact Analysis
6.2.1. By Product Type
6.2.2. By Application
6.2.3. By Sample
6.2.4. By End User
6.2.5. By Region
7. Global Molecular Transport Medium Market- Pricing Analysis
7.1. Global Average Pricing Analysis Benchmark
7.2. Pricing Assumption
8. Global Molecular Transport Medium Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2032
8.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
8.2. Current and Future Market Value (US$ Bn) Projections, 2024-2032
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
9. Global Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032, By Product Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Bn) Analysis by Product Type, 2019-2023
9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Product Type, 2024-2032
9.3.1. Active Transport Medium
9.3.2. Inactivated Transport Medium
10. Global Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032, By Application
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn) Analysis by Application, 2019-2023
10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Application, 2024-2032
10.3.1. Virus
10.3.1.1. COVID-19
10.3.1.2. Middle East respiratory syndrome (MERS)
10.3.1.3. Influenza
10.3.1.4. COVID-19
10.3.1.5. Human Immunodeficiency Virus (HIV)
10.3.1.6. Rhinovirus
10.3.1.7. Adenovirus
10.3.1.8. Respiratory Syncytial Virus (RSV)
10.3.2. Bacteria
10.3.2.1. Staphylococcus pneumonia
10.3.2.2. Haemophilus influenzae
10.3.2.3. Anthrax
10.3.2.4. Others
10.3.3. Atypical Bacteria
10.3.3.1. Mycoplasma
10.3.3.2. Q-Fever
10.3.3.3. Others
10.3.4. Mycobacterial and Fungal Infection
11. Global Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032, By Sample
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Bn) Analysis by Sample, 2019-2023
11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Sample, 2024-2032
11.3.1. Nasal Washes and Swabs
11.3.2. Sputum
11.3.3. Saliva
11.3.4. Faecal & Stool
11.3.5. Urine
11.3.6. Blood
11.3.7. Tissues
11.3.8. Others
12. Global Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032, By End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Bn) Analysis by End User, 2019-2023
12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by End User, 2024-2032
12.3.1. Diagnostic Laboratories
12.3.2. Microbiology Laboratories
12.3.3. Hospitals & Clinics
12.3.4. Others
13. Global Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Bn) Analysis by Region, 2019-2023
13.3. Current Market Size (US$ Bn) Analysis and Forecast by Region, 2024-2032
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. South Asia
13.3.5. East Asia
13.3.6. Oceania
13.3.7. Middle East and Africa (MEA)
14. North America Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032
14.1. Introduction
14.2. Historical Market Size (US$ Bn) Analysis by Market Taxonomy, 2019-2023
14.3. Market Size (US$ Bn) and Forecast by Market Taxonomy, 2024-2032
14.3.1. By Country
14.3.1.1. U.S.
14.3.1.2. Canada
14.3.2. By Product Type
14.3.3. By Application
14.3.4. By Sample
14.3.5. By End User
14.4. Market Trends
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
14.7. Country Level Analysis & Forecast
14.7.1. U.S. Molecular Transport Medium Market
14.7.1.1. Introduction
14.7.1.2. Market Analysis and Forecast by Market Taxonomy
14.7.1.2.1. By Product Type
14.7.1.2.2. By Application
14.7.1.2.3. By Sample
14.7.1.2.4. By End User
14.7.2. Canada Molecular Transport Medium Market
14.7.2.1. Introduction
14.7.2.2. Market Analysis and Forecast by Market Taxonomy
14.7.2.2.1. By Product Type
14.7.2.2.2. By Application
14.7.2.2.3. By Sample
14.7.2.2.4. By End User
15. Latin America Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032
15.1. Introduction
15.2. Historical Market Size (US$ Bn) Analysis by Market Taxonomy, 2019-2023
15.3. Market Size (US$ Bn) and Forecast by Market Taxonomy, 2024-2032
15.3.1. By Country
15.3.1.1. Brazil
15.3.1.2. Mexico
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Product Type
15.3.3. By Application
15.3.4. By Sample
15.3.5. By End User
15.4. Market Trends
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
15.7. Country Level Analysis & Forecast
15.7.1. Brazil Molecular Transport Medium Market
15.7.1.1. Introduction
15.7.1.2. Market Analysis and Forecast by Market Taxonomy
15.7.1.2.1. By Product Type
15.7.1.2.2. By Application
15.7.1.2.3. By Sample
15.7.1.2.4. By End User
15.7.2. Argentina Molecular Transport Medium Market
15.7.2.1. Introduction
15.7.2.2. Market Analysis and Forecast by Market Taxonomy
15.7.2.2.1. By Product Type
15.7.2.2.2. By Application
15.7.2.2.3. By Sample
15.7.2.2.4. By End User
15.7.3. Mexico Molecular Transport Medium Market
15.7.3.1. Introduction
15.7.3.2. Market Analysis and Forecast by Market Taxonomy
15.7.3.2.1. By Product Type
15.7.3.2.2. By Application
15.7.3.2.3. By Sample
15.7.3.2.4. By End User
16. Europe Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032
16.1. Introduction
16.2. Historical Market Size (US$ Bn) Analysis by Market Taxonomy, 2019-2023
16.3. Market Size (US$ Bn) and Forecast by Market Taxonomy, 2024-2032
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. Italy
16.3.1.3. France
16.3.1.4. U.K.
16.3.1.5. Spain
16.3.1.6. BENELUX
16.3.1.7. Nordic Countries
16.3.1.8. Russia
16.3.1.9. Rest of Europe
16.3.2. By Product Type
16.3.3. By Application
16.3.4. By Sample
16.3.5. By End User
16.4. Market Trends
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
16.7. Country Level Analysis & Forecast
16.7.1. Germany Molecular Transport Medium Market
16.7.1.1. Introduction
16.7.1.2. Market Analysis and Forecast by Market Taxonomy
16.7.1.2.1. By Product Type
16.7.1.2.2. By Application
16.7.1.2.3. By Sample
16.7.1.2.4. By End User
16.7.2. France Molecular Transport Medium Market
16.7.2.1. Introduction
16.7.2.2. Market Analysis and Forecast by Market Taxonomy
16.7.2.2.1. By Product Type
16.7.2.2.2. By Application
16.7.2.2.3. By Sample
16.7.2.2.4. By End User
16.7.3. Italy Molecular Transport Medium Market
16.7.3.1. Introduction
16.7.3.2. Market Analysis and Forecast by Market Taxonomy
16.7.3.2.1. By Product Type
16.7.3.2.2. By Sample
16.7.3.2.3. By End User
16.7.4. Spain Molecular Transport Medium Market
16.7.4.1. Introduction
16.7.4.2. Market Analysis and Forecast by Market Taxonomy
16.7.4.2.1. By Product Type
16.7.4.2.2. By Application
16.7.4.2.3. By Sample
16.7.4.2.4. By End User
16.7.5. U.K. Molecular Transport Medium Market
16.7.5.1. Introduction
16.7.5.2. Market Analysis and Forecast by Market Taxonomy
16.7.5.2.1. By Product Type
16.7.5.2.2. By Application
16.7.5.2.3. By Sample
16.7.5.2.4. By End User
16.7.6. BENELUX Union Molecular Transport Medium Market
16.7.6.1. Introduction
16.7.6.2. Market Analysis and Forecast by Market Taxonomy
16.7.6.2.1. By Product Type
16.7.6.2.2. By Application
16.7.6.2.3. By Sample
16.7.6.2.4. By End User
16.7.7. Nordic Countries Molecular Transport Medium Market
16.7.7.1. Introduction
16.7.7.2. Market Analysis and Forecast by Market Taxonomy
16.7.7.2.1. By Product Type
16.7.7.2.2. By Application
16.7.7.2.3. By Sample
16.7.7.2.4. By End User
16.7.8. Russia Molecular Transport Medium Market
16.7.8.1. Introduction
16.7.8.2. Market Analysis and Forecast by Market Taxonomy
16.7.8.2.1. By Product Type
16.7.8.2.2. By Application
16.7.8.2.3. By Sample
16.7.8.2.4. By End User
17. South Asia Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032
17.1. Introduction
17.2. Historical Market Size (US$ Bn) Analysis by Market Taxonomy, 2019-2023
17.3. Market Size (US$ Bn) and Forecast by Market Taxonomy, 2024-2032
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Thailand
17.3.1.3. Indonesia
17.3.1.4. Malaysia
17.3.1.5. Vietnam
17.3.1.6. Philippines
17.3.1.7. Rest of South Asia
17.3.2. By Product Type
17.3.3. By Application
17.3.4. By Sample
17.3.5. By End User
17.4. Market Trends
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
17.7. Country Level Analysis & Forecast
17.7.1. India Molecular Transport Medium Market
17.7.1.1. Introduction
17.7.1.2. Market Analysis and Forecast by Market Taxonomy
17.7.1.2.1. By Product Type
17.7.1.2.2. By Application
17.7.1.2.3. By Sample
17.7.1.2.4. By End User
17.7.2. Indonesia Molecular Transport Medium Market
17.7.2.1. Introduction
17.7.2.2. Market Analysis and Forecast by Market Taxonomy
17.7.2.2.1. By Product Type
17.7.2.2.2. By Application
17.7.2.2.3. By Sample
17.7.2.2.4. By End User
17.7.3. Vietnam Molecular Transport Medium Market
17.7.3.1. Introduction
17.7.3.2. Market Analysis and Forecast by Market Taxonomy
17.7.3.2.1. By Product Type
17.7.3.2.2. By Application
17.7.3.2.3. By Sample
17.7.3.2.4. By End User
17.7.4. Philippines Molecular Transport Medium Market
17.7.4.1. Introduction
17.7.4.2. Market Analysis and Forecast by Market Taxonomy
17.7.4.2.1. By Product Type
17.7.4.2.2. By Application
17.7.4.2.3. By Sample
17.7.4.2.4. By End User
17.7.5. Malaysia Molecular Transport Medium Market
17.7.5.1. Introduction
17.7.5.2. Market Analysis and Forecast by Market Taxonomy
17.7.5.2.1. By Product Type
17.7.5.2.2. By Application
17.7.5.2.3. By Sample
17.7.5.2.4. By End User
17.7.6. Thailand Molecular Transport Medium Market
17.7.6.1. Introduction
17.7.6.2. Market Analysis and Forecast by Market Taxonomy
17.7.6.2.1. By Product Type
17.7.6.2.2. By Application
17.7.6.2.3. By Sample
17.7.6.2.4. By End User
18. East Asia Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032
18.1. Introduction
18.2. Historical Market Size (US$ Bn) Analysis by Market Taxonomy, 2019-2023
18.3. Market Size (US$ Bn) Forecast by Market Taxonomy, 2024-2032
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.2. By Product Type
18.3.3. By Application
18.3.4. By Sample
18.3.5. By End User
18.4. Market Trends
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
18.7. Country Level Analysis & Forecast
18.7.1. China Molecular Transport Medium Market
18.7.1.1. Introduction
18.7.1.2. Market Analysis and Forecast by Market Taxonomy
18.7.1.2.1. By Product Type
18.7.1.2.2. By Application
18.7.1.2.3. By Sample
18.7.1.2.4. By End User
18.7.2. Japan Molecular Transport Medium Market
18.7.2.1. Introduction
18.7.2.2. Market Analysis and Forecast by Market Taxonomy
18.7.2.2.1. By Product Type
18.7.2.2.2. By Application
18.7.2.2.3. By Sample
18.7.2.2.4. By End User
18.7.3. South Korea Molecular Transport Medium Market
18.7.3.1. Introduction
18.7.3.2. Market Analysis and Forecast by Market Taxonomy
18.7.3.2.1. By Product Type
18.7.3.2.2. By Application
18.7.3.2.3. By Sample
18.7.3.2.4. By End User
19. Oceania Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032
19.1. Introduction
19.2. Historical Market Size (US$ Bn) Analysis by Market Taxonomy, 2019-2023
19.3. Market Size (US$ Bn) and Forecast by Market Taxonomy, 2024-2032
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Product Type
19.3.3. By Application
19.3.4. By Sample
19.3.5. By End User
19.4. Market Trends
19.5. Key Market Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis
19.7. Country Level Analysis & Forecast
19.7.1. Australia Molecular Transport Medium Market
19.7.1.1. Introduction
19.7.1.2. Market Analysis and Forecast by Market Taxonomy
19.7.1.2.1. By Product Type
19.7.1.2.2. By Application
19.7.1.2.3. By Sample
19.7.1.2.4. By End User
19.7.2. New Zealand Molecular Transport Medium Market
19.7.2.1. Introduction
19.7.2.2. Market Analysis and Forecast by Market Taxonomy
19.7.2.2.1. By Product Type
19.7.2.2.2. By Application
19.7.2.2.3. By Sample
19.7.2.2.4. By End User
20. Middle East and Africa (MEA) Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032
20.1. Introduction
20.2. Historical Market Size (US$ Bn) Analysis by Market Taxonomy, 2019-2023
20.3. Market Size (US$ Bn) and Forecast by Market Taxonomy, 2024-2032
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Turkey
20.3.1.3. Israel
20.3.1.4. North Africa
20.3.1.5. South Africa
20.3.1.6. Rest of Middle East and Africa
20.3.2. By Product Type
20.3.3. By Application
20.3.4. By Sample
20.3.5. By End User
20.4. Market Trends
20.5. Key Market Participants - Intensity Mapping
20.6. Drivers and Restraints - Impact Analysis
20.7. Country Level Analysis & Forecast
20.7.1. GCC Countries Molecular Transport Medium Market
20.7.1.1. Introduction
20.7.1.2. Market Analysis and Forecast by Market Taxonomy
20.7.1.2.1. By Product Type
20.7.1.2.2. By Application
20.7.1.2.3. By Sample
20.7.1.2.4. By End User
20.7.2. Israel Molecular Transport Medium Market
20.7.2.1. Introduction
20.7.2.2. Market Analysis and Forecast by Market Taxonomy
20.7.2.2.1. By Product Type
20.7.2.2.2. By Application
20.7.2.2.3. By Sample
20.7.2.2.4. By End User
20.7.3. Turkey Molecular Transport Medium Market
20.7.3.1. Introduction
20.7.3.2. Market Analysis and Forecast by Market Taxonomy
20.7.3.2.1. By Product Type
20.7.3.2.2. By Application
20.7.3.2.3. By Sample
20.7.3.2.4. By End User
20.7.4. South Africa Molecular Transport Medium Market
20.7.4.1. Introduction
20.7.4.2. Market Analysis and Forecast by Market Taxonomy
20.7.4.2.1. By Product Type
20.7.4.2.2. By Application
20.7.4.2.3. By Sample
20.7.4.2.4. By End User
20.7.5. North Africa Molecular Transport Medium Market
20.7.5.1. Introduction
20.7.5.2. Market Analysis and Forecast by Market Taxonomy
20.7.5.2.1. By Product Type
20.7.5.2.2. By Application
20.7.5.2.3. By Sample
20.7.5.2.4. By End User
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Concentration
21.4. Market Presence Analysis
21.4.1. Regional footprint of Players
21.4.2. Product footprint by Players
21.4.3. Channel Foot Print by Players
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. Thermo Fisher Scientific
22.3.1.1. Overview
22.3.1.2. Product Portfolio
22.3.1.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.1.4. Sales Footprint
22.3.1.5. Strategy Overview
22.3.1.6. Key Developments
22.3.1.7. SWOT Analysis
22.3.2. Becton Dickinson and Company
22.3.2.1. Overview
22.3.2.2. Product Portfolio
22.3.2.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.2.4. Sales Footprint
22.3.2.5. Strategy Overview
22.3.2.6. Key Developments
22.3.2.7. SWOT Analysis
22.3.3. Cardinal Health
22.3.3.1. Overview
22.3.3.2. Product Portfolio
22.3.3.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.3.4. Sales Footprint
22.3.3.5. Strategy Overview
22.3.3.6. Key Developments
22.3.3.7. SWOT Analysis
22.3.4. Quidel Corporation
22.3.4.1. Overview
22.3.4.2. Product Portfolio
22.3.4.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.4.4. Sales Footprint
22.3.4.5. Strategy Overview
22.3.4.6. Key Developments
22.3.4.7. SWOT Analysis
22.3.5. Medical Wire & Equipment (MWE)
22.3.5.1. Overview
22.3.5.2. Product Portfolio
22.3.5.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.5.4. Sales Footprint
22.3.5.5. Strategy Overview
22.3.5.6. Key Developments
22.3.5.7. SWOT Analysis
22.3.6. COPAN Diagnostics Inc. [COPAN Group]
22.3.6.1. Overview
22.3.6.2. Product Portfolio
22.3.6.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.6.4. Sales Footprint
22.3.6.5. Strategy Overview
22.3.6.6. Key Developments
22.3.6.7. SWOT Analysis
22.3.7. Titan Biotech Ltd.
22.3.7.1. Overview
22.3.7.2. Product Portfolio
22.3.7.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.7.4. Sales Footprint
22.3.7.5. Strategy Overview
22.3.7.6. Key Developments
22.3.7.7. SWOT Analysis
22.3.8. Alpha Teknova, Inc. [formerly named Teknova]
22.3.8.1. Overview
22.3.8.2. Product Portfolio
22.3.8.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.8.4. Sales Footprint
22.3.8.5. Strategy Overview
22.3.8.6. Key Developments
22.3.8.7. SWOT Analysis
22.3.9. Bio-Genex Laboratories Inc.
22.3.9.1. Overview
22.3.9.2. Product Portfolio
22.3.9.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.9.4. Sales Footprint
22.3.9.5. Strategy Overview
22.3.9.6. Key Developments
22.3.9.7. SWOT Analysis
22.3.10. EKF Diagnostics
22.3.10.1. Overview
22.3.10.2. Product Portfolio
22.3.10.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.10.4. Sales Footprint
22.3.10.5. Strategy Overview
22.3.10.6. Key Developments
22.3.10.7. SWOT Analysis
22.3.11. Trinity Biotech
22.3.11.1. Overview
22.3.11.2. Product Portfolio
22.3.11.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.11.4. Sales Footprint
22.3.11.5. Strategy Overview
22.3.11.6. Key Developments
22.3.11.7. SWOT Analysis
22.3.12. Alpha-Tec Systems, Inc.
22.3.12.1. Overview
22.3.12.2. Product Portfolio
22.3.12.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.12.4. Sales Footprint
22.3.12.5. Strategy Overview
22.3.12.6. Key Developments
22.3.12.7. SWOT Analysis
22.3.13. Charm Sciences, Inc.
22.3.13.1. Overview
22.3.13.2. Product Portfolio
22.3.13.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.13.4. Sales Footprint
22.3.13.5. Strategy Overview
22.3.13.6. Key Developments
22.3.13.7. SWOT Analysis
22.3.14. Azer Scientific
22.3.14.1. Overview
22.3.14.2. Product Portfolio
22.3.14.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.14.4. Sales Footprint
22.3.14.5. Strategy Overview
22.3.14.6. Key Developments
22.3.14.7. SWOT Analysis
22.3.15. bioBoaVista
22.3.15.1. Overview
22.3.15.2. Product Portfolio
22.3.15.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.15.4. Sales Footprint
22.3.15.5. Strategy Overview
22.3.15.6. Key Developments
22.3.15.7. SWOT Analysis
22.3.16. AccuGene
22.3.16.1. Overview
22.3.16.2. Product Portfolio
22.3.16.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.16.4. Sales Footprint
22.3.16.5. Strategy Overview
22.3.16.6. Key Developments
22.3.16.7. SWOT Analysis
22.3.17. KSL Diagnostics
22.3.17.1. Overview
22.3.17.2. Product Portfolio
22.3.17.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.17.4. Sales Footprint
22.3.17.5. Strategy Overview
22.3.17.6. Key Developments
22.3.17.7. SWOT Analysis
22.3.18. Puritan Medical Products
22.3.18.1. Overview
22.3.18.2. Product Portfolio
22.3.18.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.18.4. Sales Footprint
22.3.18.5. Strategy Overview
22.3.18.6. Key Developments
22.3.18.7. SWOT Analysis
22.3.19. Amazing Biotech (Shanghai) Co., Ltd.
22.3.19.1. Overview
22.3.19.2. Product Portfolio
22.3.19.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.19.4. Sales Footprint
22.3.19.5. Strategy Overview
22.3.19.6. Key Developments
22.3.19.7. SWOT Analysis
23. Assumptions and Acronyms Used
24. Research Methodology